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RESPONSE BY GEORGES MATHE 
I am very sorry to inform 
you that Professor Georges 
Mathe cannot be here. He 
has been ill for some time 
with a disabling disease and 
simply cannot travel. He 
asked me to express his 
heartfel t thanks for the Me-
dawar Prize, which he con-
siders to be the greatest 
honor of his life . He also sent 
me a compilation of memen-
tos of his early days in transplaritation, with a request that I 
use it to prepare a response on his behalf. The collection 
contained a photograph taken in the 1960s of a remarkable 
assembly of bone marrow transplant pioneers including Dirk 
van Bekkum, Donnall Thomas, George Santos, and John 
Trentin. Mathe was in the middle of the group. 
Mathe's preoccupation with the treatment of hematolym-
phopoietic malignancies was symbolized by a photograph of 
one of his mice, which had been cured of leukemia by total 
body irradiation and allogeneic bone marrow transplantation 
in 1958. The animal was one of only seven that survived after 
allogeneic bone marrow transplantation. Although the mor-
tality was 67% in these mice, it was 100% in animals treated 
with irradiation only or with irradiation plus isogeneic 
marrow. 
The experience with the irradiated Yugoslavian workers 
treated the next year with allogeneic bone marrow cell infu-
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sions generated worldwide attention. The possible relevance 
of this human experience to the treatment of leukemia in 
humans did not go unnoticed. These Yugoslavian patients 
were treated before there were practical ways of phenotyping 
leukocytes. However, the temporary engraftment of the do-
nor bone marrow cells was clearly validated by the presence 
of donor erythrocytes. 
Leukocyte typing had become feasible by the time of 
Mathe's-and the world's-first successful bone marrow 
transplantation in 1963, thanks to the discoveries of Jean 
Dausset, Jon von Rood , Rose Payne, Paul Terasaki, and 
others. Airtight proof of engraftment in Mathe's index case of 
bone marrow transplantation was provided by analysis of 
human leukocyte antigens (HLA) and red cell and immuno-
globulin phenotypes. Multiple familial donors were used. The 
transplanted cells that survived and repopulated the recipi-
ent were from the donor who had the best HLA compatibility. 
Tolerance to the donor was demonstrated by skin grafting. 
Discouraged by the death of this patient from chronic graft-
versus-host disease, Mathe began his research on mixed do-
nor leukocyte chimerism in antilymphocyte globulin-pre-
treated patients. After completing this pathfinding work, 
Mathe left the field of bone marrow transplantation but not 
before summarizing his experience in this book written with 
his associates Jean Louis Amiel and Leon Schwarzenberg. 
The memorabilia sent to me by Professor Mathe, which 
documented these contributions and contained additional 
personal details, were generated in the 13 years between 
1958 and 1971. The work established dominant themes , both 
in oncology and transplantation, which have steadily in-
creased in importance in the ensuing third of a century. 
Professor Mathe deeply regrets not being here to describe 
this work and to be reunited with old friends . 
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